Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Björn Tackenberg

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Journal of Neurology|December 6, 2018
Can we predict cognitive decline after initial diagnosis of multiple sclerosis? Results from the German National early MS cohort (KKNMS)Andreas Johnen, Paul-Christian Bürkner, Nils C Landmeyer, et al.
Annals of Neurology|October 12, 2012
Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08Peter K Gregersen, Roman Kosoy, Annette T Lee, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 15, 2025
Genetic Risk Variants for Multiple Sclerosis and Other Loci Linked to Intrathecal Immunoglobulin G SynthesisAlbert Pukaj, Adil Harroud, Klementy Shchetynsky, et al.
Cell Research|October 27, 2021
K<sub>2P</sub>18.1 translates T cell receptor signals into thymic regulatory T cell developmentTobias Ruck, Stefanie Bock, Steffen Pfeuffer, et al.
Annals of Clinical and Translational Neurology|August 4, 2025
Serum Neurofilament Light Chain in Multiple Sclerosis: Superiority of Age- and BMI-Corrected Z Scores/Percentiles Over Absolute Cutoff Values for Prediction of Treatment ResponseMaximilian Einsiedler, Aleksandra Maleska Maceski, Sofia Sandgren, et al.
Brain : a Journal of Neurology|November 14, 2025
GFAP and NfL as predictors of disease progression and relapse activity in fingolimod-treated multiple sclerosisAleksandra Maleska Maceski, Pascal Benkert, Maximilian Einsiedler, et al.
Nature Communications|June 21, 2018
DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosisLara Kular, Yun Liu, Sabrina Ruhrmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 30, 2020
Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severityPatrick Ostkamp, Anke Salmen, Béatrice Pignolet, et al.
Annals of Neurology|October 16, 2024
Serum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels Reflect Different Mechanisms of Disease Progression under B-Cell Depleting Treatment in Multiple SclerosisPascal Benkert, Aleksandra Maleska Maceski, Sabine Schaedelin, et al.
Genetic Epidemiology|October 27, 2015
Successful Replication of GWAS Hits for Multiple Sclerosis in 10,000 Germans Using the Exome ArrayTheresa Dankowski, Dorothea Buck, Till F M Andlauer, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Journal of Neurology|December 6, 2018
Can we predict cognitive decline after initial diagnosis of multiple sclerosis? Results from the German National early MS cohort (KKNMS)Andreas Johnen, Paul-Christian Bürkner, Nils C Landmeyer, et al.
Annals of Neurology|October 12, 2012
Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08Peter K Gregersen, Roman Kosoy, Annette T Lee, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 15, 2025
Genetic Risk Variants for Multiple Sclerosis and Other Loci Linked to Intrathecal Immunoglobulin G SynthesisAlbert Pukaj, Adil Harroud, Klementy Shchetynsky, et al.
Cell Research|October 27, 2021
K<sub>2P</sub>18.1 translates T cell receptor signals into thymic regulatory T cell developmentTobias Ruck, Stefanie Bock, Steffen Pfeuffer, et al.
Annals of Clinical and Translational Neurology|August 4, 2025
Serum Neurofilament Light Chain in Multiple Sclerosis: Superiority of Age- and BMI-Corrected Z Scores/Percentiles Over Absolute Cutoff Values for Prediction of Treatment ResponseMaximilian Einsiedler, Aleksandra Maleska Maceski, Sofia Sandgren, et al.
Brain : a Journal of Neurology|November 14, 2025
GFAP and NfL as predictors of disease progression and relapse activity in fingolimod-treated multiple sclerosisAleksandra Maleska Maceski, Pascal Benkert, Maximilian Einsiedler, et al.
Nature Communications|June 21, 2018
DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosisLara Kular, Yun Liu, Sabrina Ruhrmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 30, 2020
Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severityPatrick Ostkamp, Anke Salmen, Béatrice Pignolet, et al.
Annals of Neurology|October 16, 2024
Serum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels Reflect Different Mechanisms of Disease Progression under B-Cell Depleting Treatment in Multiple SclerosisPascal Benkert, Aleksandra Maleska Maceski, Sabine Schaedelin, et al.
Genetic Epidemiology|October 27, 2015
Successful Replication of GWAS Hits for Multiple Sclerosis in 10,000 Germans Using the Exome ArrayTheresa Dankowski, Dorothea Buck, Till F M Andlauer, et al.
Pageof 9